Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000224647 ("novel protein phosphatase inhibitor 2 domain pseudogene") is a non-protein-coding pseudogene identified in the human genome, based on sequence similarity to protein phosphatase inhibitor family members. It does not encode a functional protein and does not participate in protein phosphatase inhibition or cellular signaling. Its annotation as a pseudogene means it is a genomic relic of a once-active gene, potentially harboring mutations that disrupt its coding ability and biological function[2][5]. Pseudogenes are generally non-functional, though some may play regulatory roles at the RNA level, which has not been documented for this locus[2].
None. Mechanisms of action are not applicable since this gene does not encode an active protein[2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel protein phosphatase inhibitor 2 domain pseudogene (ENSG00000224647).